SEC Form 4 · accession 0001209191-18-032802
ChemoCentryx, Inc. · CCXI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James L Tyree
Director
Period of report
May 21, 2018
Accepted (ET)
May 23, 2018 · 9:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001340652
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | May 21, 2018 | A | 8,421 | A | — | — | Common Stock | 8,421 | 8,421 | D |
| Stock Option (Right to buy)F3 | $12.94 | May 21, 2018 | A | 13,352 | A | — | May 21, 2028 | Common Stock | 13,352 | 13,352 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.
- F2The restricted stock units awarded on May 21, 2018 vests on the first anniversary of the grant date, subject to the Reporting Person's continued employment or service relationship with the Company on such vesting date. Shares will be delivered to the Reporting Person within thirty (30) days following the vesting date.
- F3The option was granted on May 21, 2018. The award vests and becomes exercisable on the first anniversary of the grant date, subject to the Reporting Person's continued employment or service relationship with the Company on such vesting date.